We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves New Antidepressant, Iron Deficiency Treatment
FDA Approves New Antidepressant, Iron Deficiency Treatment
July 26, 2013
The FDA last week approved a new antidepressant developed by Forest Laboratories and partner Pierre Fabre Laboratories, and finally granted Luitpold Pharmaceuticals’ NDA for its iron deficiency anemia (IDA) treatment Injectafer.